XXE New Technology, Physiological Systems, Measurement
Non-billable header ICD10PCS Release FY2026-APR
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| FY2026 | 2025-10-01 | 2026-03-31 | New Technology, Physiological Systems, Measurement | no |
| FY2026-APR | 2026-04-01 | current | New Technology, Physiological Systems, Measurement | no |
Related codes in XXE
- XXE0X07 Measurement of Intracranial Vascular Activity, Computer-aided Assessment, New Technology Group 7
- XXE0X1A Measurement of Intracranial Cerebrospinal Fluid Flow, Computer-aided Triage and Notification, New Technology Group 10
- XXE0X48 Measurement of Brain Electrical Activity, Computer-aided Semiologic Analysis, New Technology Group 8
- XXE2X19 Measurement of Cardiac Output, Computer-aided Assessment, New Technology Group 9
- XXE3X27 Measurement of Pulmonary Artery Flow, Computer-aided Triage and Notification, New Technology Group 7
- XXE3X58 Measurement of Coronary Artery Flow, Quantitative Flow Ratio Analysis, New Technology Group 8
- XXE3X68 Measurement of Coronary Artery Flow, Computer-aided Valve Modeling and Notification, New Technology Group 8
- XXE5X2A Measurement of Infection, Phenotypic Fully Automated Rapid Susceptibility Technology with Controlled Inoculum, New Technology Group 10
- XXE5X38 Measurement of Infection, Whole Blood Reverse Transcription and Quantitative Real-time Polymerase Chain Reaction, New Technology Group 8
- XXE5X4A Measurement of Infection, Positive Blood Culture Small Molecule Sensor Array Technology, New Technology Group 10
- XXE5X5A Measurement of Immune Response, Whole Blood Cellular Assessment via Microfluidic Deformability, New Technology Group 10
- XXE5XBB Measurement of Infection and Immune Response, Gene Expression Testing System, New Technology Group 11
- XXE5XR7 Measurement of Infection, Mechanical Initial Specimen Diversion Technique Using Active Negative Pressure, New Technology Group 7
- XXE5XT7 Measurement of Intracranial Arterial Flow, Whole Blood mRNA, New Technology Group 7
- XXE5XV7 Measurement of Infection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection, New Technology Group 7
- XXE5XY9 Measurement of Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology, New Technology Group 9
- XXE97U7 Measurement of Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction, New Technology Group 7
- XXEZXAB Measurement of Macronutrient Content, Computer-aided Assessment for Nutrition Management, New Technology Group 11
- XXEZXCB Measurement of Infection, Computer-aided Triage and Notification, New Technology Group 11